In Q1 2023, the median transaction value in healthcare was $30 million. In Q1 2023, strategic buyers accounted for 97% of transactions.
Select recent notable publicly announced M&A transactions:
– Fall Line Endurance Fund announced its acquisition of GreenLight Biosciences Holdings for $179 million in March 2023.
– TM Strategic Capital Equity; TM Strategic Capital Debt closed its acquisition of Tactical Medical Solutions for $106 million in March 2023.
– Echo Lake Capital announced its acquisition of Quince Therapeutics for $60 million in March 2023.
– Concentra Biosciences announced its acquisition of Jounce Therapeutics for $108 million in March 2023.
– WW International announced its acquisition of Weekend Health for $131 million in March 2023.Download Report